Filippo Manti

Dr. Filippo Manti

Department of Neuroscience and Mental Health, Azienda Ospedaliero Universitaria Policlinico Umberto, Via dei Sabelli 108, 00185 Rome, Italy
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in Molecular Genetics and Metabolism
Verified
Journal Article
Closed access
FMFilippo Manti
Filippo Manti
FNfrancesca nardecchia
francesca nardecchia
FCFlavia Chiarotti
Flavia Chiarotti
Claudia CarducciClaudia Carducci
Claudia Carducci
CCCarla Carducci
Carla Carducci
VLVincenzo Leuzzi
Vincenzo Leuzzi

29 October 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
FFFrancesca Fioriello
Francesca Fioriello
AMAndrea Maugeri
Andrea Maugeri
Livio D'AlviaLivio D'Alvia
Livio D'Alvia
EPErika Pittella
Erika Pittella
EPEmanuele Piuzzi
Emanuele Piuzzi
CSCarla Sogos
Carla Sogos
Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by early impairment in social and communication domains and autonomic nervous system unbalance. This study evaluated heart rate (HR) as a possible indicator of stress response in children with ASD as compared to children with language disorder (LD). Twenty-four patients [mean age = 42.62 months; SD = 8.14 months,12 with ASD (10 M/2F) and 12 with LD (8 M/4F)] underwent clinical [Leiter International Performance Scale-Revised, Autism Diagnostic Observation Schedule, second edition (ADOS-2)] and physiological evaluation (HR monitoring) during five interactive activities, while wearing an HR measurement device. IQ (ASD:IQ = 103.33 ± 12.85 vs. LD:IQ = 111.00 ± 8.88, p = 0.103) and fluid reasoning on the Leiter-R Scale were within the normal range in all subjects. Increased HR during the third activity (ADOS-2 bubble play) significantly correlated with autistic symptoms (r = 0.415; p = 0.044), while correlations between ADOS-2 total score and HR during the first activity (ADOS-2 free play; r = 0.368; p = 0.077), second activity (Leiter-R figure ground subscale; r = 0.373, p = 0.073), and fifth activity (ADOS-2 anticipation of a routine with objects; r = 0.368; p = 0.076) did not quite reach statistical significance. Applying a linear regression model, we found that the ADOS-2 total score significantly influenced HR variations (p = 0.023). HR monitoring may provide a better understanding of the stress-provoking situations for children with ASD. Furthermore, it could help clinicians detect the impact of the stressful condition on the autistic core and adress treatment strategy.

28 October 2017 in European Child & Adolescent Psychiatry
Verified
Journal Article
Closed access
PDF file
FCFlavia Capozzi
Flavia Capozzi
FMFilippo Manti
Filippo Manti
MTMichela Di Trani
Michela Di Trani
MRMaria Romani
Maria Romani
MVMiriam Vigliante
Miriam Vigliante
Carla SogosCarla Sogos
Carla Sogos

10 May 2024 in Brain Sciences
Verified
Journal Article
Open access
PDF file
DEDario Esposito
Dario Esposito
GCGianluca Cruciani
Gianluca Cruciani
LZLaura Zaccaro
Laura Zaccaro
ECEmanuele Di Carlo
Emanuele Di Carlo
GSGrazia Fernanda Spitoni
Grazia Fernanda Spitoni
TPTiziana Pascucci
Tiziana Pascucci
Hyperserotonemia is one of the most studied endophenotypes in autism spectrum disorder (ASD), but there are still no unequivocal results about its causes or biological and behavioral outcomes. This systematic review summarizes the studies investigating the relationship between blood serotonin (5-HT) levels and ASD, comparing diagnostic tools, analytical methods, and clinical outcomes. A literature search on peripheral 5-HT levels and ASD was conducted. In total, 1104 publications were screened, of which 113 entered the present systematic review. Of these, 59 articles reported hyperserotonemia in subjects with ASD, and 26 presented correlations between 5-HT levels and ASD-core clinical outcomes. The 5-HT levels are increased in about half, and correlations between hyperserotonemia and clinical outcomes are detected in a quarter of the studies. The present research highlights a large amount of heterogeneity in this field, ranging from the characterization of ASD and control groups to diagnostic and clinical assessments, from blood sampling procedures to analytical methods, allowing us to delineate critical topics for future studies.

17 October 2019 in Frontiers in Pediatrics
Verified
Journal Article
Open access
PDF file
FMFilippo Manti
Filippo Manti
FGFederica Giovannone
Federica Giovannone
CSCarla Sogos
Carla Sogos
Background: Generalized anxiety and oppositional defiant disorders are among the most common psychopathological disorders in pre-school children. We investigated the symptom rate and perception of the child's disorders in parents of preschool children with generalized anxiety disorder (GAD) or oppositional defiant disorder (ODD). Methods: The parents of preschool children (mean age 54.35 months, SD ± 11.60) with ODD, GAD, or typical development (TD) filled the Symptom Check List-90-Revised (SCL-90-R) and the Child Behavior Checklist- 1½−5 (CBCL 1½ 5). Parents and children's diagnoses were determined by clinical assessment. Results: The parents of children with ODD reported a symptoms rate higher than parents of children with GAD or TD on most of the SCL-90-R (Global Severity Index of mental distress, p = 0.010; Somatization, p = 0.002; Paranoid Ideation, p < 0.000; and Phobic Anxiety scales, p = 0.030). Conclusions: On the CBCL scales, the parents of the ODD group overestimated the children's problems, while parents of children with GAD reported mainly children's emotional difficulties. Parents of children with ODD seem to be psychologically more vulnerable than parents of children with GAD. Parenting programs might be tailored considering the child's diagnosis and family functioning.

14 January 2021 in Journal of Inherited Metabolic Disease
Verified
Journal Article
Open access
PDF file
OHOya Kuseyri Hübschmann
Oya Kuseyri Hübschmann
AMAlexander Mohr
Alexander Mohr
JFJennifer Friedman
Jennifer Friedman
FMFilippo Manti
Filippo Manti
GHGabriella Horvath
Gabriella Horvath
IHInga Harting
Inga Harting
Inherited monoamine neurotransmitter disorders (iMNDs) are rare disorders with clinical manifestations ranging from mild infantile hypotonia, movement disorders to early infantile severe encephalopathy. Neuroimaging has been reported as non‐specific. We systematically analyzed brain MRIs in order to characterize and better understand neuroimaging changes and to re‐evaluate the diagnostic role of brain MRI in iMNDs. 81 MRIs of 70 patients (0.1‐52.9 years, 39 patients with tetrahydrobiopterin deficiencies, 31 with primary disorders of monoamine metabolism) were retrospectively analyzed and clinical records reviewed. 33/70 patients had MRI changes, most commonly atrophy (n = 24). Eight patients, six with dihydropteridine reductase deficiency (DHPR), had a common pattern of bilateral parieto‐occipital and to a lesser extent frontal and/or cerebellar changes in arterial watershed zones. Two patients imaged after acute severe encephalopathy had signs of profound hypoxic‐ischemic injury and a combination of deep gray matter and watershed injury (aromatic l‐amino acid decarboxylase (AADCD), tyrosine hydroxylase deficiency (THD)). Four patients had myelination delay (AADCD; THD); two had changes characteristic of post‐infantile onset neuronal disease (AADCD, monoamine oxidase A deficiency), and nine T2‐hyperintensity of central tegmental tracts. iMNDs are associated with MRI patterns consistent with chronic effects of a neuronal disorder and signs of repetitive injury to cerebral and cerebellar watershed areas, in particular in DHPRD. These will be helpful in the (neuroradiological) differential diagnosis of children with unknown disorders and monitoring of iMNDs. We hypothesize that deficiency of catecholamines and/or tetrahydrobiopterin increase the incidence of and the CNS susceptibility to vascular dysfunction.